2025 Q3 -tulosraportti
59 päivää sitten42 min
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
190 201
Myynti
Määrä
100 587
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 10 973 | - | - | ||
| 13 475 | - | - | ||
| 6 039 | - | - | ||
| 18 961 | - | - | ||
| 9 749 | - | - |
Ylin
0,214VWAP
Alin
0,198VaihtoMäärä
1,2 6 100 814
VWAP
Ylin
0,214Alin
0,198VaihtoMäärä
1,2 6 100 814
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr, FactSet| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 24.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 26.11.2025 | |
| 2025 Q2 -tulosraportti | 28.8.2025 | |
| 2025 Q1 -tulosraportti | 14.5.2025 | |
| 2024 Q4 -tulosraportti | 25.2.2025 | |
| 2024 Q3 -tulosraportti | 27.11.2024 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·21 t sittenNews: ”Immunovia (IMMNOV: Nasdaq Stockholm), a diagnostic company in pancreatic cancer, announced today that the company will participate in the investor meeting Aktiesparna Digital Temakväll Life Science. CEO and President Jeff Borcherding will present the company's commercial strategy and launch activities. On January 26, 2026 at 7:20 PM CET, Immunovia will present its strategic plan and operational priorities for the commercialization of the PancreaSure test. In connection with the presentation, the company's CEO and President, Jeff Borcherding, will provide further information on the latest developments in the business, including Immunovia's recently obtained regulatory approval in California which enables the sale of PancreaSure in the state.”
·2 päivää sitten · MuokattuWhat a tragic stock this is. Well, it's actually expected to see red figures after a green rise with this stock for now. I also think it's typical for this type of company at this stage of development. But this is tough stuff to hold onto. You're holding the stock because you've had faith. And you'd rather not have it turn into FOMO. Suddenly news comes, but there seems to be little news that truly makes people happy and enthusiastic. https://forum.placera.se/inlagg/34c9f451-3613-4ca6-ab70-b3f718f9a156 @Biggleby Nothing particularly new under the sun, really. Only unrest in the stock market. Yes, the US dollar can be crushed by the world if one so wishes. But probably everything else will be tried before selling one's US bonds. yes, maybe the outside world and gold price will do something. But still, it is listed on the stock exchange in Sweden. The market being tested is USA, latest news from democratically-governed California about Immunovia. I see it that way. Nothing significant has happened other than annoying Greenland rhetoric. Give the orange man another distraction please. The man (brat) has been absolutely crazy for many years, even though he is now assumed to have progressive dementia with an assumed 2-4 months lifespan before he leaves this world. Saw a YouTube from a doctor about it. But such things can be inaccurate. https://www.youtube.com/watch?v=CBCDYjd150I&t=146s 11 months ago It has been in the cards that the USA was heading towards fascism already when judges and democrats threw in the towel before the election results 2025 were available. It's only recently that it's so much clearer. Now people won't be as quick "as me" to realize such things, because I've followed it a little bit. Already when "Humphrey's Executor v. United States" was on its knees many months ago. That's when I really saw the warning signs.
·2 päivää sitten · MuokattuApproval in California, according to my interpretation, is a clear path forward where more is expected to come. The withdrawal of the reverse split is a result of that.
·2 päivää sittenThere are not that many states that impose these extra requirements. The big ones are California and new York, which impose extra requirements on the lab and quality control there. For most other states, their labs already have certification.·18 t sittenWell, but surely no one expected their lab routines to be in such poor condition that they weren't allowed to sell in California. It's surely baked into expectations that they should be able to sell throughout the entire country, otherwise this would have been an important milestone that would have been announced and followed beforehand.- ·3 päivää sitten · Muokattu@Aktier1234 og Biggleby. Placera-forum https://forum.placera.se/inlagg/a4b9b663-5130-4bd3-b799-2ae0cbc5b0bf Disagree. Can be good in a somewhat longer time horizon. But operating on stock exchanges in two different markets is difficult. Furthermore, penny-stocks carry a delisting risk, especially on US exchanges. You are forced into RS more frequently there. I don't know if delisting is a threat on the Stockholm Stock Exchange. It doesn't seem that way. Because the stock has been a penny stock for a terribly long time without us hearing any warnings
- ·3 päivää sitten · MuokattuActually a bit incredible that such news only takes one back to price levels we had a few days ago, despite +12% and more gains during the day. No, this stock still looks too weighed down if you ask me. Very disappointed in today's modest gain! 🤦😭·3 päivää sittenIt matches the biggest daily drops that there have been. Let's see in a few months.·3 päivää sitten · Muokattu@Vilihoo The volume probably reflects more that it reached back to where people could afford to small-trade again? So some will probably still go out a bit and wait before they go in again. These small price levels of stagnation are absolutely not healthy for confidence, for a simmering market that is necessary for people to make small profits. As it has been, a small investor would at most be able to earn tens of kroner and hundreds of kroner if you account for brokerage fees on somewhat medium-sized orders. It has been a tough period for day traders, I think. We also need a bit of day trading, whether one likes or dislikes that form of trading
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
59 päivää sitten42 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·21 t sittenNews: ”Immunovia (IMMNOV: Nasdaq Stockholm), a diagnostic company in pancreatic cancer, announced today that the company will participate in the investor meeting Aktiesparna Digital Temakväll Life Science. CEO and President Jeff Borcherding will present the company's commercial strategy and launch activities. On January 26, 2026 at 7:20 PM CET, Immunovia will present its strategic plan and operational priorities for the commercialization of the PancreaSure test. In connection with the presentation, the company's CEO and President, Jeff Borcherding, will provide further information on the latest developments in the business, including Immunovia's recently obtained regulatory approval in California which enables the sale of PancreaSure in the state.”
- ·2 päivää sitten · MuokattuWhat a tragic stock this is. Well, it's actually expected to see red figures after a green rise with this stock for now. I also think it's typical for this type of company at this stage of development. But this is tough stuff to hold onto. You're holding the stock because you've had faith. And you'd rather not have it turn into FOMO. Suddenly news comes, but there seems to be little news that truly makes people happy and enthusiastic. https://forum.placera.se/inlagg/34c9f451-3613-4ca6-ab70-b3f718f9a156 @Biggleby Nothing particularly new under the sun, really. Only unrest in the stock market. Yes, the US dollar can be crushed by the world if one so wishes. But probably everything else will be tried before selling one's US bonds. yes, maybe the outside world and gold price will do something. But still, it is listed on the stock exchange in Sweden. The market being tested is USA, latest news from democratically-governed California about Immunovia. I see it that way. Nothing significant has happened other than annoying Greenland rhetoric. Give the orange man another distraction please. The man (brat) has been absolutely crazy for many years, even though he is now assumed to have progressive dementia with an assumed 2-4 months lifespan before he leaves this world. Saw a YouTube from a doctor about it. But such things can be inaccurate. https://www.youtube.com/watch?v=CBCDYjd150I&t=146s 11 months ago It has been in the cards that the USA was heading towards fascism already when judges and democrats threw in the towel before the election results 2025 were available. It's only recently that it's so much clearer. Now people won't be as quick "as me" to realize such things, because I've followed it a little bit. Already when "Humphrey's Executor v. United States" was on its knees many months ago. That's when I really saw the warning signs.
- ·2 päivää sitten · MuokattuApproval in California, according to my interpretation, is a clear path forward where more is expected to come. The withdrawal of the reverse split is a result of that.·2 päivää sittenThere are not that many states that impose these extra requirements. The big ones are California and new York, which impose extra requirements on the lab and quality control there. For most other states, their labs already have certification.·18 t sittenWell, but surely no one expected their lab routines to be in such poor condition that they weren't allowed to sell in California. It's surely baked into expectations that they should be able to sell throughout the entire country, otherwise this would have been an important milestone that would have been announced and followed beforehand.
- ·3 päivää sitten · Muokattu@Aktier1234 og Biggleby. Placera-forum https://forum.placera.se/inlagg/a4b9b663-5130-4bd3-b799-2ae0cbc5b0bf Disagree. Can be good in a somewhat longer time horizon. But operating on stock exchanges in two different markets is difficult. Furthermore, penny-stocks carry a delisting risk, especially on US exchanges. You are forced into RS more frequently there. I don't know if delisting is a threat on the Stockholm Stock Exchange. It doesn't seem that way. Because the stock has been a penny stock for a terribly long time without us hearing any warnings
- ·3 päivää sitten · MuokattuActually a bit incredible that such news only takes one back to price levels we had a few days ago, despite +12% and more gains during the day. No, this stock still looks too weighed down if you ask me. Very disappointed in today's modest gain! 🤦😭·3 päivää sittenIt matches the biggest daily drops that there have been. Let's see in a few months.·3 päivää sitten · Muokattu@Vilihoo The volume probably reflects more that it reached back to where people could afford to small-trade again? So some will probably still go out a bit and wait before they go in again. These small price levels of stagnation are absolutely not healthy for confidence, for a simmering market that is necessary for people to make small profits. As it has been, a small investor would at most be able to earn tens of kroner and hundreds of kroner if you account for brokerage fees on somewhat medium-sized orders. It has been a tough period for day traders, I think. We also need a bit of day trading, whether one likes or dislikes that form of trading
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
190 201
Myynti
Määrä
100 587
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 10 973 | - | - | ||
| 13 475 | - | - | ||
| 6 039 | - | - | ||
| 18 961 | - | - | ||
| 9 749 | - | - |
Ylin
0,214VWAP
Alin
0,198VaihtoMäärä
1,2 6 100 814
VWAP
Ylin
0,214Alin
0,198VaihtoMäärä
1,2 6 100 814
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr, FactSet| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 24.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 26.11.2025 | |
| 2025 Q2 -tulosraportti | 28.8.2025 | |
| 2025 Q1 -tulosraportti | 14.5.2025 | |
| 2024 Q4 -tulosraportti | 25.2.2025 | |
| 2024 Q3 -tulosraportti | 27.11.2024 |
2025 Q3 -tulosraportti
59 päivää sitten42 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr, FactSet| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 24.2. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 26.11.2025 | |
| 2025 Q2 -tulosraportti | 28.8.2025 | |
| 2025 Q1 -tulosraportti | 14.5.2025 | |
| 2024 Q4 -tulosraportti | 25.2.2025 | |
| 2024 Q3 -tulosraportti | 27.11.2024 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·21 t sittenNews: ”Immunovia (IMMNOV: Nasdaq Stockholm), a diagnostic company in pancreatic cancer, announced today that the company will participate in the investor meeting Aktiesparna Digital Temakväll Life Science. CEO and President Jeff Borcherding will present the company's commercial strategy and launch activities. On January 26, 2026 at 7:20 PM CET, Immunovia will present its strategic plan and operational priorities for the commercialization of the PancreaSure test. In connection with the presentation, the company's CEO and President, Jeff Borcherding, will provide further information on the latest developments in the business, including Immunovia's recently obtained regulatory approval in California which enables the sale of PancreaSure in the state.”
- ·2 päivää sitten · MuokattuWhat a tragic stock this is. Well, it's actually expected to see red figures after a green rise with this stock for now. I also think it's typical for this type of company at this stage of development. But this is tough stuff to hold onto. You're holding the stock because you've had faith. And you'd rather not have it turn into FOMO. Suddenly news comes, but there seems to be little news that truly makes people happy and enthusiastic. https://forum.placera.se/inlagg/34c9f451-3613-4ca6-ab70-b3f718f9a156 @Biggleby Nothing particularly new under the sun, really. Only unrest in the stock market. Yes, the US dollar can be crushed by the world if one so wishes. But probably everything else will be tried before selling one's US bonds. yes, maybe the outside world and gold price will do something. But still, it is listed on the stock exchange in Sweden. The market being tested is USA, latest news from democratically-governed California about Immunovia. I see it that way. Nothing significant has happened other than annoying Greenland rhetoric. Give the orange man another distraction please. The man (brat) has been absolutely crazy for many years, even though he is now assumed to have progressive dementia with an assumed 2-4 months lifespan before he leaves this world. Saw a YouTube from a doctor about it. But such things can be inaccurate. https://www.youtube.com/watch?v=CBCDYjd150I&t=146s 11 months ago It has been in the cards that the USA was heading towards fascism already when judges and democrats threw in the towel before the election results 2025 were available. It's only recently that it's so much clearer. Now people won't be as quick "as me" to realize such things, because I've followed it a little bit. Already when "Humphrey's Executor v. United States" was on its knees many months ago. That's when I really saw the warning signs.
- ·2 päivää sitten · MuokattuApproval in California, according to my interpretation, is a clear path forward where more is expected to come. The withdrawal of the reverse split is a result of that.·2 päivää sittenThere are not that many states that impose these extra requirements. The big ones are California and new York, which impose extra requirements on the lab and quality control there. For most other states, their labs already have certification.·18 t sittenWell, but surely no one expected their lab routines to be in such poor condition that they weren't allowed to sell in California. It's surely baked into expectations that they should be able to sell throughout the entire country, otherwise this would have been an important milestone that would have been announced and followed beforehand.
- ·3 päivää sitten · Muokattu@Aktier1234 og Biggleby. Placera-forum https://forum.placera.se/inlagg/a4b9b663-5130-4bd3-b799-2ae0cbc5b0bf Disagree. Can be good in a somewhat longer time horizon. But operating on stock exchanges in two different markets is difficult. Furthermore, penny-stocks carry a delisting risk, especially on US exchanges. You are forced into RS more frequently there. I don't know if delisting is a threat on the Stockholm Stock Exchange. It doesn't seem that way. Because the stock has been a penny stock for a terribly long time without us hearing any warnings
- ·3 päivää sitten · MuokattuActually a bit incredible that such news only takes one back to price levels we had a few days ago, despite +12% and more gains during the day. No, this stock still looks too weighed down if you ask me. Very disappointed in today's modest gain! 🤦😭·3 päivää sittenIt matches the biggest daily drops that there have been. Let's see in a few months.·3 päivää sitten · Muokattu@Vilihoo The volume probably reflects more that it reached back to where people could afford to small-trade again? So some will probably still go out a bit and wait before they go in again. These small price levels of stagnation are absolutely not healthy for confidence, for a simmering market that is necessary for people to make small profits. As it has been, a small investor would at most be able to earn tens of kroner and hundreds of kroner if you account for brokerage fees on somewhat medium-sized orders. It has been a tough period for day traders, I think. We also need a bit of day trading, whether one likes or dislikes that form of trading
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
190 201
Myynti
Määrä
100 587
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 10 973 | - | - | ||
| 13 475 | - | - | ||
| 6 039 | - | - | ||
| 18 961 | - | - | ||
| 9 749 | - | - |
Ylin
0,214VWAP
Alin
0,198VaihtoMäärä
1,2 6 100 814
VWAP
Ylin
0,214Alin
0,198VaihtoMäärä
1,2 6 100 814
Välittäjätilasto
Dataa ei löytynyt